Results 241 to 250 of about 81,984 (293)

Relief of Ischemia in Ischemic Cardiomyopathy

Current Cardiology Reports, 2021
Ischemic heart disease is among the most common causes of morbidity and mortality worldwide. In its stable manifestation, obstructing coronary artery stenoses prevent myocardial blood flow from matching metabolic needs of the heart under exercise conditions, which manifests clinically as dyspnea or chest pain.
Francesco, Moroni, Zachary, Gertz, Lorenzo, Azzalini   +2 more
openaire   +2 more sources

Lipomatous metaplasia in ischemic cardiomyopathy

Journal of Cardiovascular Medicine, 2009
Lipomatous metaplasia is characterized by substitution of muscle fibers with adipose tissue in the context of a myocardial scar. Cardiac magnetic resonance is an accurate cardiac imaging technique with high tissue spatial resolution that can easily characterize scar tissue, adipose tissue and lipomatous metaplasia.
DI BELLA, Gianluca, GAETA, Michele, Anfuso C, ZITO, Concetta, Patanè S, CARERJ, Scipione, ARRIGO, Francesco, COGLITORE, Sebastiano   +7 more
openaire   +2 more sources

Therapy of Ischemic Cardiomyopathy with Pentoxifylline

Angiology, 1990
Abnormal blood rheology is a known characteristic of coronary artery disease. The authors evaluated the effects of pentoxifylline on the exercise capacity ejection fraction and symptoms of 9 patients with ischemic cardiomyopathy. All patients had signs and symptoms of left ventricular dysfunction.
J C, Barnett, R C, Touchon
openaire   +2 more sources

Surgical remodeling in ischemic cardiomyopathy

Current Treatment Options in Cardiovascular Medicine, 2003
Ischemic cardiomyopathy has a very poor prognosis, despite significant advances in pharmacologic therapy in the past decade. Orthotopic heart transplantation is an option for only a small minority of patients. Due to donor shortage and a finite outcome after transplant, nontransplant surgical intervention should be intensively investigated.
James O., O'Neill, Randall C., Starling
openaire   +2 more sources

Ventricular reconstruction for ischemic cardiomyopathy

The Annals of Thoracic Surgery, 2003
Left ventricular surgical reconstruction has been advocated for patients with coronary artery disease, prior myocardial infarction, and poor left ventricular function. The objective of the approach is to resect or exclude all akinetic or dyskinetic nonfunctioning portions of the ventricular cavity and to restore the left ventricle size and shape toward
Lynda L, Mickleborough, Naeem, Merchant, Yves, Provost, Susan, Carson, Joan, Ivanov   +4 more
openaire   +2 more sources

The Arrhythmogenic Substrate in Ischemic and Non-ischemic Cardiomyopathies

2001
For the mechanistic study of arrhythmias in clinical practice the terms “arrhythmogenic substrate”, “initiating factor” and “modulating factors” have been introduced.1 We define the substrate as “a pre-existing condition that forms a prerequisite for the induction of an arrhythmia”.
Coronel, R., Baartscheer, A., Rademaker, J. M. E., Vermeulen, J. T., de Bakker, J. M. T.   +4 more
openaire   +2 more sources

Gender Differences in Ischemic Cardiomyopathy

Current Atherosclerosis Reports, 2018
Cardiovascular disease remains the leading cause of death among women globally, majority of which are due to ischemic heart disease. Despite the recent advances in the overall management of CVD, there are unique challenges in the diagnosis and management of women as well as poorer outcomes.Women with ischemic cardiomyopathy experience significant ...
Laura, Divoky, Anbukarasi, Maran, Bhavadharini, Ramu   +2 more
openaire   +2 more sources

Ischemic cardiomyopathy: Pathophysiologic mechanisms

Progress in Cardiovascular Diseases, 1990
SCHEMIC cardiomyopathy is an anatomic condition emanating from a sustained imbalance between oxygen supply and demand of the heart that, in turn, leads to myocyte loss with resultant myocardial scarring and ventricular failure. Cell loss can occur as a result of focal narrowing or occlusion of the main coronary arteries by atherosclerosis, spasm of the
P, Anversa, E H, Sonnenblick
openaire   +2 more sources

Chagas cardiomyopathy and ischemic stroke

Expert Review of Cardiovascular Therapy, 2006
American trypanosomiasis, known as Chagas disease is a major cause of cardiomyopathy in South America. Irreversible damage to the heart can appear 10-20 years after chagasic infection. The relationship between Chagas cardiomyopathy and ischemic stroke has been reviewed.
openaire   +2 more sources

Functional morphology of ischemic cardiomyopathy

Arkhiv patologii, 2014
To show that ischemic cardiomyopathy (ICM) that is generally believed to be a variant of chronic heart disease (CHD) and an analogue of chronic heart failure is an initial stage and the background of all further forms of CHD.Sixty cardiac biopsies obtained from patients during aortocoronary bypass surgery for CHD and myocardia from 55 rabbits in which ...
V S, Paukov, A S, Gavrish, V A, Krichkevich   +2 more
openaire   +2 more sources